Zobrazeno 1 - 10
of 166
pro vyhledávání: '"M S Kaminski"'
Autor:
G J Weiner, M S Kaminski
Publikováno v:
The Journal of Immunology. 144:2436-2445
The emergence of Id variants is a major escape mechanism from anti-Id therapy of human B cell malignancies and of the murine B cell lymphoma 38C13. To determine what impact the epitope specificity of anti-Id antibodies has on the prevention of emerge
Autor:
K F, Koral, Y, Dewaraja, J, Li, C L, Barrett, D D, Regan, K R, Zasadny, S G, Rommelfanger, I R, Francis, M S, Kaminski, R L, Wahl
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 41(9)
A study of the use of 131I-labeled anti-B1 monoclonal antibody, proceeded by an unlabeled predose, for therapy of previously untreated non-Hodgkin's lymphoma patients has recently been completed at the University of Michigan, Ann Arbor. More than hal
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 41(6)
131I-anti-B1 (CD20) radioimmunotherapy (RIT) is a promising approach for treatment of non-Hodgkin's lymphoma (NHL). We assessed the tumor metabolic response to RIT using FDG PET.We examined 14 patients with NHL, who were given first a tracer dose of
Autor:
K F, Koral, J, Li, Y, Dewaraja, C L, Barrett, D D, Regan, K R, Zasadny, S G, Rommelfanger, I R, Francis, M S, Kaminski, R L, Wahl
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5
In patients with non-Hodgkin's lymphoma being treated by I-131-radiolabeled anti-B1 monoclonal antibody, we test the hypothesis that the activity taken up in tumors during therapy is the same as that observed during tracer evaluation, except for scal
Autor:
R L, Wahl, K R, Zasadny, D, MacFarlane, I R, Francis, C W, Ross, J, Estes, S, Fisher, D, Regan, S, Kroll, M S, Kaminski
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39
Iodine-131 anti-B1 antibody radioimmunotherapy for B-cell lymphoma was previously reported to have substantial antitumor activity in B-cell non-Hodgkin's lymphoma (NHL) after failures of standard and salvage chemotherapy. In this article, the Univers
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39(7)
The expected effective dose equivalent to an individual from contact with 131I anti-B1 radioimmunotherapy (RIT) patients released immediately after therapeutic infusion was estimated.Effective dose equivalents were calculated retrospectively using da
Publikováno v:
Cancer. 80
In treatment of non-Hodgkin's lymphoma patients with predose-plus-I-131-labeled anti-B1 (anti-CD20) monoclonal antibody, an intratherapy single photon emission computed tomography (SPECT) image is an important part of research estimates of tumor dosi
Publikováno v:
Digestive diseases and sciences. 42(7)
Infiltration of the liver by secondary malignancies is a rare cause of acute liver failure. Acute liver failure caused by malignant infiltration is associated with almost 100% mortality and is typically diagnosed postmortem. Richter's transformation
Autor:
K F, Koral, K R, Zasadny, M L, Kessler, J Q, Luo, S F, Buchbinder, M S, Kaminski, I, Francis, R L, Wahl
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 35(10)
A method for performing 131I quantitative SPECT imaging is described which uses the superimposition of markers placed on the skin to accomplish fusion of computed tomography (CT) and SPECT image sets.To calculate mean absorbed dose after administrati
Publikováno v:
Journal of the American Optometric Association. 64(12)
Oxidative damage caused by free radicals has been implicated in the development of age-related macular degeneration (ARMD). Recent studies suggest that antioxidant vitamins and minerals can be useful for the management and/or prevention of this condi